Acceptance of annual awards of Deferred Shares DISCOVERY LIMITED (Incorporated in the Republic of South Africa) (Registration number 1999/007789/06) Legal Entity Identifier: 378900245A26169C8132 JSE share code: DSY, DSBP DSY ISIN: ZAE000022331 DSBP ISIN: ZAE000158564 Bond company code: DSYI (the "Group" or "Discovery" or the "Company") ACCEPTANCE OF ANNUAL AWARDS OF SHARES IN TERMS OF THE DEFERRED PORTION OF THE SINGLE INCENTIVE PLAN ("SIP") AND THE DISCOVERY BEE EMPLOYEE SHARE TRUST ("BEE") In compliance with paragraphs 3.63 to 3.74 and paragraphs 6.42 to 6.53 of the JSE Limited Listings Requirements and Debt Listings Requirements, notification is hereby given that certain executive directors of the Company, a prescribed officer of the Company and directors of major subsidiaries have accepted annual awards of ordinary shares allocated in terms of the deferred portion of the SIP through the Discovery Long-Term Incentive Plan Trust ("LTIP Trust") and the Group company secretary has accepted an award of ordinary shares allocated in terms of the BEE Share Trust. The deferred portion of the SIP is awarded based on the performance criteria as per the SIP for the year ended 30 June 2023 and is settled in equity held on behalf of participants by the LTIP Trust. The share awards of the deferred portion of the SIP and BEE are subject to continued employment. The nature of the interest in respect of each of these awards is indirect beneficial. The transactions have occurred off-market and the necessary clearances have been obtained. The allocations are set out below: Executive Director Number of shares Acceptance date Reference Price* Deemed Transaction of Discovery Limited accepted (all figures in R) Value (all figures in R) A Gore 64 244 30 November 2023 142.45 9 151 558 D M Viljoen 49 864 30 November 2023 142.45 7 103 127 B Swartzberg 62 470(2) 30 November 2023 142.45 8 898 852 Executive directors' share awards vest equally from the 3rd to the 5th anniversaries of these awards (between 30 September 2026 and 30 September 2028). Directors of Number of shares Company Acceptance date Reference Price* Deemed Transaction major accepted (all figures in Value (all figures subsidiaries and R) in R) prescribed officer H D Kallner 159 659(1) Discovery Limited 30 November 2023 142.45 22 743 425 (prescribed officer) J Broomberg 53 153(2) Discovery Health 30 November 2023 142.45 7 571 645 F Chothia 11 326 Discovery Health 30 November 2023 142.45 1 613 389 A Ntsaluba 40 558 Discovery Health 30 November 2023 142.45 5 777 487 N Pitje 9 733 Discovery Health 30 November 2023 142.45 1 386 466 S A Cohen 10 768 Discovery Life 30 November 2023 142.45 1 533 902 K S Rabson 34 884 Discovery Life 30 November 2023 142.45 4 969 226 R J Van Reenen 29 959 Discovery Life 30 November 2023 142.45 4 267 660 Prescribed officers and directors of major subsidiaries' share awards vest equally from the 1st to the 3rd anniversaries of these awards (between 30 September 2024 and 30 September 2026). Company secretary of Number of shares Acceptance date Reference Price* Deemed Transaction Discovery Limited accepted (all figures in R) Value (all figures in R) A Ceba 3 510 30 November 2023 142.45 500 000 (1) Includes award in respect of special Outperformance SIP (on- target value reduced with increase in reward for stretch performance) (2) Includes award in respect of Vitality Global Outperformance Plan BEE share awards vest equally from the 2nd to the 5th anniversaries of these awards (between 30 September 2025 and 30 September 2028). *The reference price has been used in determining the share allocations and represents volume weighted average traded price of the Company's shares for the 5 days ended September 2023. Sandton 1 December 2023 Equity and Debt Sponsor RAND MERCHANT BANK (a division of FirstRand Bank Limited) Date: 01-12-2023 05:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.